Session I: September 6, 2023

According to the American Cancer Society, there is a dramatic increase in the number of men being diagnosed with prostate cancer overall, and those diagnosed with later stage disease is escalating. Black men are experiencing the harshest impact from this crisis. There is an urgent need to address increasing early detection screening for this population. This session examined this need with a focus on the numbers, today’s screening guidelines for Black men, the potential impact of accelerating screening and the role of active surveillance.

Session I Program

Watch Video     Welcome and Opening Remarks: Mr. Thomas Farrington, President and Founder, PHEN

Watch Video     Remarks: Congressman Gregory W. Meeks (D5-NY)

Watch Video     Moderator:  J. Jacques Carter, MD, MPH, Assistant Professor, Harvard Medical School

Watch Video     Understanding Today’s Needs – A Look at the Numbers: Keith Crawford, MD, PhD,  PHEN Director of Clinical Trials & Patient Education

Prostate Cancer Screening Guidelines for Black Men

• • Watch Video     NCCN Guidelines: Simpa Salami, MD, MPH, Assistant Professor, University of Michigan Health, Michigan Medicine, Member of the NCCN Prostate Cancer Early Detection Screening Panel
  • Watch Video     AUA Guidelines: Daniel Barocas, MD, MPH, FACS, Professor, Vanderbilt University Medical Center, Member of the AUA Prostate Cancer Early Detection Screening Panel
  • Watch Video     USPSTF Guidelines: John B. Wong, MD, Vice Chair of Academic Affairs, Department of Medicine, Tufts Medical Center, Member of US Preventive Services Task Force

Watch Video     Prostate Cancer Screening Guidelines for Black Men: Questions & Answers Panel

Watch Video     Can Accelerated Screening Eliminate the Racial Mortality Disparity? Dr. Keith Crawford

Watch Video     Active Surveillance and Black Men: Curtis A. Pettaway, MD, Department of Urology, MD Anderson Cancer Center

Closing Remarks: Mr. Thomas Farrington